Skip to main content
. 2023 Mar 16;18(3):e0282688. doi: 10.1371/journal.pone.0282688

Fig 2. Patient disposition and withdrawals: A randomized controlled study to evaluate the co-administration of AYUSH-64 with Standard of Care (SOC) in–mild-moderate symptomatic COVID-19 (CONSORT flow diagram).

Fig 2